» Articles » PMID: 38473791

The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia

Abstract

Androgenetic alopecia is a highly prevalent condition mainly affecting men. This complex trait is related to aging and genetics; however, multiple other factors, for example, lifestyle, are also involved. Despite its prevalence, the underlying biology of androgenetic alopecia remains elusive, and thus advances in its treatment have been hindered. Herein, we review the functional anatomy of hair follicles and the cell signaling events that play a role in follicle cycling. We also discuss the pathology of androgenetic alopecia and the known molecular mechanisms underlying this condition. Additionally, we describe studies comparing the transcriptional differences in hair follicles between balding and non-balding scalp regions. Given the genetic contribution, we also discuss the most significant risk variants found to be associated with androgenetic alopecia. A more comprehensive understanding of this pathology may be generated through using multi-omics approaches.

Citing Articles

Changes and Correlation Between Hormones, Immunoglobulins, and Minerals in Blood Serum and Hair of Tianzhu White Yaks of Different Ages and Gender.

Deng Y, Shi B, Qi Y, Luo Z, Cui C, Chen S Animals (Basel). 2025; 15(5).

PMID: 40075965 PMC: 11899661. DOI: 10.3390/ani15050682.


Black phosphorus nanosheets encapsulated microneedle for multifunctional therapy for androgenic alopecia.

Xiong S, Li Z, Jiao S, Xiao T, Wu Y, Chen C J Nanobiotechnology. 2025; 23(1):147.

PMID: 40016758 PMC: 11866876. DOI: 10.1186/s12951-025-03242-z.


Polyphenols from Nanostructured with Gold Nanoparticles Stimulate Hair Growth Through Apoptosis Modulation in C57BL/6 Mice.

Perez-Mora S, Ocampo-Lopez J, Gomez-Garcia M, Salgado-Hernandez S, Flores-Martinez Y, Perez-Ishiwara D Pharmaceutics. 2025; 17(2).

PMID: 40006589 PMC: 11859437. DOI: 10.3390/pharmaceutics17020222.


Application of platelet-rich plasma lysate combined with hyaluronic acid microneedles for the treatment of alopecia.

Suo Z, Xu Y, Zhang A, Cao Y, Liu J, Wang H Drug Deliv Transl Res. 2025; .

PMID: 39982641 DOI: 10.1007/s13346-025-01816-w.


Lasers for treatment of androgenetic alopecia: an in-depth analysis.

Gupta A, Taylor D, Nouri K Lasers Med Sci. 2025; 40(1):108.

PMID: 39979533 DOI: 10.1007/s10103-025-04365-3.


References
1.
Ohnemus U, Uenalan M, Inzunza J, Gustafsson J, Paus R . The hair follicle as an estrogen target and source. Endocr Rev. 2006; 27(6):677-706. DOI: 10.1210/er.2006-0020. View

2.
Ghonemy S, Alarawi A, Bessar H . Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation. J Dermatolog Treat. 2019; 32(2):236-241. DOI: 10.1080/09546634.2019.1654070. View

3.
JOHNSTONE M . Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol. 1997; 124(4):544-7. DOI: 10.1016/s0002-9394(14)70870-0. View

4.
Arck P, Handjiski B, Peters E, Peter A, Hagen E, Fischer A . Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol. 2003; 162(3):803-14. PMC: 1868104. DOI: 10.1016/S0002-9440(10)63877-1. View

5.
Paus R, Christoph T, Muller-Rover S . Immunology of the hair follicle: a short journey into terra incognita. J Investig Dermatol Symp Proc. 2000; 4(3):226-34. DOI: 10.1038/sj.jidsp.5640217. View